Patient-Specific VR Action Observa… for Parkinson's (NCT07250672)
Virtual reality improves walking coordination
- Trial ID
- NCT07250672
- Official Title
- Examining the Effect of Action Observation Training Using Patient-Specific 3D Records in Parkinson's Patients
- Goal
- Virtual reality improves walking coordination
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Abant Izzet Baysal University
- Study Type
- INTERVENTIONAL
- Enrollment
- 24 participants
- Conditions
- Parkinson Disease, Virtual Reality, Action Obervation Training, Immersive Virtual Reality, 3d Recording
- Interventions
- Patient-Specific VR Action Observation Training, Healthy-Model VR Action Observation Training
Summary For Families
The goal is to help people with mild to moderate Parkinson's improve walking and everyday motor skills by strengthening the brain circuits that plan and mirror movement. The approach uses immersive virtual reality so you watch 3D recordings, either of your own movements or of a healthy model, to activate motor learning pathways and encourage smoother, more coordinated actions; this is a non-drug rehab method used alongside your usual antiparkinsonian medications, not a replacement for levodopa. The trial is looking for people aged 50 to 85 with Parkinson's at Hoehn and Yahr stage 3 or lower who can walk independently and are on stable antiparkinsonian meds, excluding those with other neurological disorders, recent medication changes, significant 3D vision problems, or pronounced simulator sickness.
Locations
- Abant Izzet Baysal University Faculty of Health Science, Bolu, Bolu, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Patient-Specific VR Action Observation Training. The goal is to help people with mild to moderate Parkinson's improve walking and everyday motor skills by strengthening the brain circuits that plan and mirror movement. The approach uses immersive virtual reality so you watch 3D recordings, either of your own movements or of a healthy model, to activate motor learning pathways and encourage smoother, more coordinated actions; this is a non-drug rehab method used alongside your usual antiparkinsonian medications, not a replacement for levodopa. The trial is looking for people aged 50 to 85 with Parkinson's at Hoehn and Yahr stage 3 or lower who can walk independently and are on stable antiparkinsonian meds, excluding those with other neurological disorders, recent medication changes, significant 3D vision problems, or pronounced simulator sickness.
- Who can participate?
- Participants must be between 50 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 7 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.